It is currently Sun Mar 26, 2017 4:54 pm
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials (2017)
https://link.springer.com/article/10.10 ... 017-0232-0
The objective of this study was to evaluate the effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on serum magnesium in hypomagnesemic patients with type 2 diabetes.
This post hoc analysis was based on pooled data from four placebo-controlled studies ...
Total posts 237099 • Total topics 25716 • Total members 17008